The Mass Spectrometry Center's expertise and available applications in biomarker identification and characterization are outlined below.
Biomarker identification can consist of discovery approaches followed by validation of candidates using targeted quantification. Validation of biomarker quantification methods using FDA guidance and GLP-regulated analysis of biomarkers is also available.
- Discovery metabolomics, lipidomics, and/or proteomics
- Mass spectrometry imaging for biomarker discovery or biomarker spatial localization
- Targeted metabolomics, targeted lipidomics
- Biomarker validation